30 Mar 23
A pharma company in-licensed a new product in the final stages of regulatory approval but had no medical affairs team to support product launch.
tranScrip assembled a team comprising a medical affairs physician, a medical information specialist, a medical writer and a project manager to support peri-launch.
The product was launched as planned and a phase IV clinical trial programme was designed and initiated.
Get in touch to see how our senior cross-functional experts can help you reduce risk, protect value, and move forward with confidence.